The tandem mass spectrometry newborn screening experience in North Carolina: 1997–2005

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Inherited Metabolic Disease

• Publication date

  2006-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10545-006-0228-9PMID 16601872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Y42H mutation in medium-chain acyl-CoA dehydrogenase, which is prevalent in babies identified by MS/MS-based newborn screening, is temperature sensitive.

  2004cited by this paper
• Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany

  2004cited by this paper
• Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening

  2003cited by this paper
• Screening newborns for inborn errors of metabolism by tandem mass spectrometry.

  2003cited by this paper
• Rare Disorders of Metabolism with Elevated Butyryl- and Isobutyryl-Carnitine Detected by Tandem Mass Spectrometry Newborn Screening

  2003cited by this paper
• Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.

  2003cited by this paper
• Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns.

  2003cited by this paper
• Newborn Screening for Metabolic Diseases

  2002cited by this paper
• Glutaric acidemia, type I, missed by newborn screening in an infant with dystonia following promethazine administration.

  2001cited by this paper
• Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.

  2001influential reference
• The magnitude and challenge of false-positive newborn screening test results.

  2000cited by this paper
• Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.

  1993cited by this paper
• Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism

  1990cited by this paper
• AN AUTOMATED PROCEDURE FOR BLOOD PHENYLALANINE.

  1965cited by this paper

• Epidemiology of Hyperphenylalaninemia: A Systematic Review and Meta-Analysis

  2026cites this paper
• Review: Utility of mass spectrometry in rare disease research and diagnosis

  2025cites this paper
• Expanded Newborn Screening for Inborn Errors of Metabolism at a Single Center in Louisiana (2005–2024): Outcomes

  2025cites this paper
• Medium-Chain Acyl-CoA Dehydrogenase Deficiency Disorder as a Cause of Acute Liver Failure in a 23-Month-Old Baby

  2025cites this paper
• Incidence of Organic Acid Disorders in 13 Million Chinese Newborns: A Systematic Review and Meta-Analysis

  2025cites this paper
• Milder Form of Cobalamin C Disease May Be Missed by Newborn Screening: The Importance of Methylmalonic Acid Assessment

  2025cites this paper
• A 25-Year Retrospective on Bavaria’s Newborn Screening Programme: Achievements, Challenges and Long-Term Follow-Up

  2025cites this paper
• SUDEP in inherited metabolic epilepsies.

  2025cites this paper
• Short and Long‐Term Outcomes of Liver Transplantation in Pediatric Patients With Inborn Errors of Metabolism: A Single‐Center Study

  2025cites this paper
• Large-scale newborn screening for organic acidemias in Quanzhou, China: a 10-year retrospective observational study

  2025cites this paper
• Early-Onset Inherited Metabolic Diseases: When Clinical Symptoms Precede Newborn Screening—Insights from Emilia-Romagna (Italy)

  2025cites this paper
• Cost-effectiveness analysis of tandem mass spectrometry compared to fluorescence analysis for screening neonatal genetic metabolic diseases

  2025cites this paper
• Tandem mass spectrometry in screening for inborn errors of metabolism: comprehensive bibliometric analysis

  2025cites this paper
• Newborn screening and genetic diagnosis of 3-methylcrotonyl-CoA carboxylase deficiency in Quanzhou,China

  2024cites this paper
• Promises and challenges of genomic newborn screening (NBS) – lessons from public health NBS programs

  2024cites this paper
• A newborn Screening Programme for Inborn errors of metabolism in Galicia: 22 years of evaluation and follow-up

  2024influential citation
• Functional Analysis of Novel Variants Located in the Tetramerization Loop of ACAT1.

  2024cites this paper
• Selective screening for inborn errors of metabolism using tandem mass spectrometry in West Kazakhstan children: study protocol

  2024cites this paper
• Disease spectrum, prevalence, genetic characteristics of inborn errors of metabolism in 21,840 hospitalized infants in Chongqing, China, 2017-2022

  2024cites this paper
• [Clinical and genetic features of children with 3-methylcrotonyl-coenzyme A carboxylase deficiency: an analysis of six cases].

  2024cites this paper
• Newborn screening for isovaleric acidemia: A case report of a Chinese patient with novel variants

  2024cites this paper
• Spectrum of Organic Aciduria Diseases in Tunisia: A 35-year Retrospective Study

  2024cites this paper
• How mass spectrometry revolutionized newborn screening

  2024cites this paper
• Biochemical and molecular characteristics among infants with abnormal newborn screen for very-long-chain acyl-CoA dehydrogenase deficiency: A single center experience

  2023cites this paper
• Re-Imagining Drug Discovery using Mass Spectrometry.

  2023cites this paper
• Incidence and genetic variants of inborn errors of metabolism identified through newborn screening: A 7‐year study in eastern coastal areas of China

  2023cites this paper
• Successfully Navigating Food and Drug Administration Orphan Drug and Rare Pediatric Disease Designations for AAV9-hPCCA Gene Therapy: The National Institutes of Health Platform Vector Gene Therapy Experience

  2023influential citation
• Screening of 1.17 million newborns for inborn errors of metabolism using tandem mass spectrometry in Shanghai, China: A 19-year report.

  2023cites this paper
• A False-Negative Newborn Screen for Tyrosinemia Type 1—Need for Re-Evaluation of Newborn Screening with Succinylacetone

  2023cites this paper
• Inborn Errors of Metabolism in Iran: First Report from Iran Metabolic Registry

  2023cites this paper
• Newborn Screening of Primary Carnitine Deficiency: An Overview of Worldwide Practices and Pitfalls to Define an Algorithm before Expansion of Newborn Screening in France

  2023cites this paper
• Spectrum Analysis of Inherited Metabolic Disorders for Expanded Newborn Screening in a Central Chinese Population

  2022cites this paper
• Diagnosis of inborn errors of metabolism within the expanded newborn screening in the Madrid region

  2022cites this paper
• Extended risk of mortality in children with inborn errors of metabolism: a longitudinal cohort study.

  2022cites this paper
• Tandem Mass Spectrometry Screening for Inborn Errors of Metabolism in Newborns and High-Risk Infants in Southern China: Disease Spectrum and Genetic Characteristics in a Chinese Population

  2021influential citation
• Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis

  2021cites this paper
• Organic Acidemias and Disorders of Fatty Acid Oxidation

  2021cites this paper
• Glutaric Acidemia type 1 with Atypical Acylcarnitine Profile During Newborn Screening

  2021cites this paper
• Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders

  2021cites this paper
• C4OH is a potential newborn screening marker—a multicenter retrospective study of patients with beta-ketothiolase deficiency in China

  2021cites this paper
• [New Inborn Errors of Metabolism added in the French program of neonatal screening].

  2021cites this paper
• Evaluation of diagnostic accuracy of biomarkers of inborn errors of metabolism in sick neonates: A prospective observational study

  2021cites this paper
• Newborn Screening for Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase and Mitochondrial Trifunctional Protein Deficiencies Using Acylcarnitines Measurement in Dried Blood Spots—A Systematic Review of Test Accuracy

  2021cites this paper
• Biochemical and molecular features of Chinese patients with glutaric acidemia type 1 detected through newborn screening

  2021cites this paper
• Prevalence of methylmalonic acidemia among newborns and the clinical-suspected population: a meta-analyse

  2021cites this paper
• Screening and follow-up results of fatty acid oxidative metabolism disorders in 608 818 newborns in Jining, Shandong province.

  2021cites this paper
• Institutional experience of newborn screening for inborn metabolism disorders by tandem MS in the Turkish population

  2020cites this paper
• Development of Strategies to Decrease False Positive Results in Newborn Screening

  2020cites this paper
• Expanded Screening of One Million Swedish Babies with R4S and CLIR for Post-Analytical Evaluation of Data

  2020cites this paper
• C4OH is a Potential Screening Marker - A Multicenter Retrospective Study of Patients with Beta-Ketothiolase Deficiency in China

  2020cites this paper
• Newborn screening timeliness quality improvement initiative: Impact of national recommendations and data repository

  2020cites this paper
• Biochemical assays of TCA cycle and β-oxidation metabolites.

  2020cites this paper
• Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project.

  2020cites this paper
• Management Principles for Acute Illness in Patients With Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency

  2020cites this paper
• A 7-Year Report of Spectrum of Inborn Errors of Metabolism on Full-Term and Premature Infants in a Chinese Neonatal Intensive Care Unit

  2020cites this paper
• Expanded newborn screening for inborn errors of metabolism by tandem mass spectrometry in newborns from Xinxiang city in China

  2020cites this paper
• Incidence of inborn errors of metabolism detected by tandem mass spectrometry in China: A census of over seven million newborns between 2016 and 2017

  2020cites this paper
• Inborn errors of metabolism detectable by tandem mass spectrometry in Beijing

  2020cites this paper
• Neonatal Macrosomia is an Interfering Factor for Analytes on the Colorado State Newborn Screen.

  2020cites this paper
• The Effect of Amino Acid, Carbohydrate, and Lipid Metabolism Disorders on Eyes

  2020cites this paper
• Prenatal Diagnosis of Glutaric Acidemia I Based on Amniotic Fluid Samples in 42 Families Using Genetic and Biochemical Approaches

  2020cites this paper
• Systematic literature review and meta-analysis on the epidemiology of propionic acidemia

  2019cites this paper
• Newborn Screening and Diagnosis of Inborn Errors of Metabolism: A 5-year Study in An Eastern Chinese Population.

  2019cites this paper
• Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review

  2019cites this paper
• Application of Next-Generation Sequencing Following Tandem Mass Spectrometry to Expand Newborn Screening for Inborn Errors of Metabolism: A Multicenter Study

  2019influential citation
• Hypermethioninemia in Campania: Results from 10 years of newborn screening

  2019cites this paper
• The Role of Technology in Newborn Screening

  2019cites this paper
• Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency

  2019cites this paper
• Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a southern Chinese population.

  2019cites this paper
• Two Infants With Beta-Ketothiolase Deficiency Identified by Newborn Screening in China

  2019cites this paper
• A nationwide retrospective observational study of population newborn screening for medium‐chain acyl‐CoA dehydrogenase (MCAD) deficiency in the Netherlands

  2019cites this paper
• Individualized metabolomics: opportunities and challenges

  2019influential citation
• Selective Screening of Fatty Acids Oxidation Defects and Organic Acidemias by Liquid Chromatography/tandem Mass Spectrometry Acylcarnitine Analysis in Brazilian Patients.

  2018influential citation
• JIMD Reports, Volume 39

  2018cites this paper
• Lipid biomarkers for the peroxisomal and lysosomal disorders: their formation, metabolism and measurement.

  2018cites this paper
• Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence

  2018cites this paper
• Metabolic Signatures of Cystic Fibrosis Identified in Dried Blood Spots For Newborn Screening Without Carrier Identification.

  2018cites this paper
• Recent advances in understanding beta-ketothiolase (mitochondrial acetoacetyl-CoA thiolase, T2) deficiency

  2018cites this paper
• Beta-Ketothiolase Deficiency Presenting with Metabolic Stroke After a Normal Newborn Screen in Two Individuals.

  2018cites this paper
• Medium-chain acyl-CoA dehydrogenase deficiency: Two novel ACADM mutations identified in a retrospective screening

  2018cites this paper
• [Screening for newborn organic aciduria in Zhejiang province:prevalence, outcome and follow-up].

  2017cites this paper
• Infant with hepatomegaly and hypoglycemia: A setting for fatty acid oxidation defects

  2017cites this paper
• [Screening for amino acid metabolic disorders of newborns in Zhejiang province:prevalence, outcome and follow-up].

  2017cites this paper
• Comparison of Methods of Initial Ascertainment in 58 Cases of Propionic Acidemia Enrolled in the Inborn Errors of Metabolism Information System Reveals Significant Differences in Time to Evaluation and Symptoms at Presentation

  2017cites this paper
• Two Libyan siblings with beta-ketothiolase deficiency: A case report and review of literature

  2017influential citation
• Selective Screening for Inborn Errors of Metabolism: A Report of Six Years Experience

  2017cites this paper
• Clinical presentation and outcome in a series of 32 patients with 2-methylacetoacetyl-coenzyme A thiolase (MAT) deficiency.

  2017cites this paper
• Chapter 6 – Newborn screening

  2017cites this paper
• Optimization of liquid chromatographic parameters for untargeted metabolomics of dried blood spots

  2017cites this paper
• Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: The first newborn screening pilot study

  2016cites this paper
• Expanded newborn screening by mass spectrometry: New tests, future perspectives.

  2016cites this paper
• Inborn Errors of Metabolism That Cause Sudden Infant Death: A Systematic Review with Implications for Population Neonatal Screening Programmes

  2016cites this paper
• Seven novel mutations of the SMPD1 gene in four Chinese patients with Niemann-Pick disease type A and prenatal diagnosis for four fetuses.

  2016cites this paper
• [Pancytopenia and metabolic decompensation in a neonate].

  2016cites this paper
• 3-Methylcrotonyl-CoA carboxylase deficiency: Mutational spectrum derived from comprehensive newborn screening.

  2016cites this paper
• Vision of correction for classic homocystinuria.

  2016cites this paper
• Beta-Ketothiolase Deficiency Resolving Challenges in Diagnosis

  2016cites this paper
• Neonatal Screening for Inherited Metabolic Diseases in 2016.

  2016cites this paper
• The status of neonatal screening in China, 2013

  2016cites this paper
• Spectrum Analysis of Common Inherited Metabolic Diseases in Chinese Patients Screened and Diagnosed by Tandem Mass Spectrometry

  2015cites this paper